Edilytics

Precision analytics for genome editing. Creators of CRISPResso2.

[Edilytics @edilytics]

@QuinlanSievers The website should be back up! Enjoy your daily CRISPResso and please don’t hesitate if you run into anymore issues

[Edilytics @edilytics]

Thanks for using CRISPResso!

[Profluent @ProfluentBio]

Scientific sharing fuels progress. Our friends at @Edilytics developed CRISPResso, an open-source CRISPR analysis tool built for researchers.

Together with OpenCRISPR-1, the future of customizable gene editing is more accessible than ever.

Check it out: https://t.co/77UhIuRh6Z

[Edilytics @edilytics]

We are thrilled to be a part of @BioUtah!

[BioUtah @BioUtah]

🎉 Welcome, @Edilytics, to @BioUtah!

Their flagship product, CRISPResso, is the industry standard for analyzing genome editing events from NGS data, supporting diverse editing modalities with 1,650+ citations in academia & industry.

🔗 Learn more: https://t.co/zEoHJL2UsF

[Edilytics @edilytics]

We are excited to attend @CSHL's CRISPR Frontiers conference next week. Let us know if you are going and we can talk all things genome editing analysis!

[Edilytics @edilytics]

Congratulations to @CRISPRTX and @VertexPharma for UK approval of Casgevy to treat sickle-cell disease and β-thalassaemia.

Hope to continue to see more therapies brought closer to the clinic!
https://t.co/JzqiZG9aDI

[Edilytics @edilytics]

Excellent talk @grunewaju! #esgct

(Thanks for using CRISPResso in your slides and work)

[Edilytics @edilytics]

Happy #WorldCRISPRDay! To celebrate we would like to announce the launch of https://t.co/VTOYILnR3k.

Join us in celebration by analyzing your #CRISPR experiment, happy analyzing!

[Edilytics @edilytics]

Our team is excited to be at the @ESGCT congress next week! If you are going we would love to meet you in person, feel free to reach out so that we can connect.

[Edilytics @edilytics]

Fascinating protocol from Changtian Pan @PCT71158462 & Yiping Qi constructing CRISPR-Combo systems for speed breeding of genome-edited plants. Thanks for using #CRISPResso in your analysis!

https://t.co/woug8HpyMG

[Edilytics @edilytics]

Congratulations to Bestas et al. on their paper illustrating a new nuclease with lower off-targets and translocations.

Thanks for using CRISPResso! https://t.co/1rFtUQDWZC

[Edilytics @edilytics]

Excited to be at @CSHL's #CRISPR Frontier meeting this week. If you are there too, send a DM and would love to connect!

[Edilytics @edilytics]

Congratulations to Alex Reed, Benjamin Cravatt, @jfernandobazan, et al. on their groundbreaking paper utilizing #CRISPR technology to show the role of TMEM164 in ferroptosis.

Thanks for using #crispresso2
https://t.co/mRepGpqMOe

[Edilytics @edilytics]

Congratulations to Mohr, Damas, Gudmand-Høyer, et al. on their groundbreaking @ACSSynBio paper utilizing #CRISPR technology for precise genetic engineering.

Thank you for using #crispresso2!

https://t.co/DoLY0QIdG8

[Edilytics @edilytics]

Congrats to Kaiqin She, Yi Liu, Qinyu Zhao, et al. on their recent paper on correcting mutations and phenotypes in retinal degenerative mice using split prime editing.

Thanks for using #crispresso2

https://t.co/a09CTyQjX6

[Edilytics @edilytics]

Congrats to Fuminori Tanihara, Maki Hiratat, et al. on their recent paper using electroporation and #CRISPR to cause an INS point mutation in pigs!

Thanks for using #crispresso2!
https://t.co/n1d0bmS3DW

[Edilytics @edilytics]

Congrats to @kaisa_pakari @WittbrodtLab @_ThomThum_ et al. on their recent paper on de novo PAM generation to reach initially inaccessible target sites for base editing .

Thanks for using #crispresso2
https://t.co/p6Z06EY0Z6

[Edilytics @edilytics]

Congrats to Li, et al. on their recent paper developing prime editing.

Thanks for using #crispresso2!
https://t.co/Qb5t5wiZEi

[Edilytics @edilytics]

Congrats to Jin, et al. on their recent paper on how to circumvent barriers to in vivo #CRISPR use.

Thanks for using #crispresso2!
https://t.co/eBE6fBd2S4

[Edilytics @edilytics]

Congrats to Liao, Chen, Hsiao, Jiang, et al. on their recent paper using #CRISPR base editing to potentially treat inherited monogenic blood disorders!

Thanks for using #crispresso2!
https://t.co/N4Ozvl7LVy